priors.science/reviews/motor-neurone-disease-treatment

Motor Neurone Disease Treatment

The current evidence on 6 claims, ordered from most established to most contested. Each score is the panel’s evidence certainty — how firmly the literature supports the claim as stated.

6claims tracked
38primary papers reviewed
9 Aug 2026latest evidence review
Weeklyre-scored against new papers
1 Established · 2 Likely · 1 Uncertain · 2 Doubtful  |  four-reviewer panel · PICO Framework
ClaimStandingEvidence certaintyCorpus
Tofersen lowers neurofilamentDMTEstablished86%7
Non-invasive ventilation prolongs survivalCareLikely72%7
Riluzole prolongs survivalDMTLikely71%6
Multidisciplinary care prolongs survivalCareUncertain50%5
Edaravone slows declineDMTDoubtful47%8
Sodium phenylbutyrate-taurursodiol prolongs survivalDMTDoubtful30%5
Track Motor Neurone Disease Treatment.
These claims are re-scored against new papers every week. Track this topic for the full review, including each claim’s challenge and the papers behind it.
Track this topic →
Standing — what the evidence certainty means
Established≥ 85%Strong, consistent evidence. Unlikely to change.
Likely70–84%Well supported, with some gaps or indirect evidence.
Uncertain50–69%Mixed or limited evidence. Genuinely open.
Doubtful30–49%Little support; the weight of evidence leans against it.
Refuted< 30%The evidence contradicts it — confidently false as stated.